1. Current Threat of Nitrosamines in Pharmaceuticals and Scientific Strategies for Risk Mitigation;Tuesuwan;J Pharm Sci,2023
2. Control of nitrosamine impurities in human drugs,2021
3. U.S. Food and Drug Administration. Drug Recalls n.d. https://www.fda.gov/drugs/drug-safety-and-availability/drug-recalls (accessed July 28, 2023).
4. Nitrosamine impurities in medications: guidance,2023
5. Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk,2017